Functional and Structural Characterization of Treatment-Emergent Nirmatrelvir Resistance Mutations at Low Frequencies in the Main Protease (Mpro) Reveals a Unique Evolutionary Route for SARS-CoV-2 to Gain Resistance

Our new Mpro clinical mutations that confer complete resistance to NIR were not identified during previous cell-culture-based studies. More research is needed to explore resistance mechanisms, providing insights into strategies that mitigate resistance and protect therapeutic efficacy.

Authors

Institutions

Publication Details

Journal
The Journal of Infectious Diseases
Published
2025-06-02
DOI
https://doi.org/10.1093/infdis/jiaf294
Citations
1
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
1.40

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Functional and Structural Characterization of Treatment-Emergent Nirmatrelvir Resistance Mutations at Low Frequencies in the Main Protease (Mpro) Reveals a Unique Evolutionary Route for SARS-CoV-2 to Gain Resistance

Natalie M. Deschenes, Calem Kenward, Abdullah Moinuddin, Allison McGeer et al.
1 citations
The Journal of Infectious Diseases
SARS-CoV-2 and COVID-19 Research
1.40
article

Functional and Structural Characterization of Treatment-Emergent Nirmatrelvir Resistance Mutations at Low Frequencies in the Main Protease (Mpro) Reveals a Unique Evolutionary Route for SARS-CoV-2 to Gain Resistance

Natalie M. Deschenes, Calem Kenward, Abdullah Moinuddin, Allison McGeer, Merrilee Thomas, Patryk Aftanas, N.C.J. Strynadka, L.J. Worrall, Robert Andrew Kozak, Lubna Farooqi, Mark Paetzel, Aoxiang Li, Finlay Maguire, François Jean, W.A. Mosimann, Iqbal Malik, Jason R. Smith, Robert N. Young, Artem Cherkasov, Jimena Pérez‐Vargas, Maxime Lefebvre, Zoë Zhong, Jeonghwan Lim, Nicholas Waglechner, Lina Siddiqi
article en
1 citations

Abstract

Our new Mpro clinical mutations that confer complete resistance to NIR were not identified during previous cell-culture-based studies. More research is needed to explore resistance mechanisms, providing insights into strategies that mitigate resistance and protect therapeutic efficacy.

The Journal of Infectious DiseasesVol. 232(5)
Mount Sinai Hospital (CA), Dalhousie University (CA), Sunnybrook Health Science Centre (CA), University of British Columbia (CA), Simon Fraser University (CA), University of Toronto (CA), Montana Molecular (United States) (US), Prevention of Organ Failure (CA), Sinai Health System (CA), The Prostate Centre (GB), Sunnybrook Hospital (CA), Sunnybrook Research Institute
University of Saskatchewan, National Research Council Sri Lanka, Canada Foundation for Innovation, National Institutes of Health, Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 20%
SARS-CoV-2 and COVID-19 Research
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.